ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Risk of second primary cancers in patients with rectal neuroendocrine neoplasms: a surveillance, epidemiology, and end results analysis

Wan, Ming; Wu, Jiaqi; Jiang, Zhaopeng; Gong, Wushuang; Zhou, Xianli*哈尔滨医科大学
Frontiers in Oncology2023-9-13DOI: 10.3389/fonc.2023.1248268
7阅读
引用收藏
分享

摘要

BackgroundWhile an elevated risk of second primary cancers (SPCs) has been observed in many other cancers, risk of SPCs has not been quantified in patients with rectal neuroendocrine neoplasms (NENs).MethodsSurvivors of primary rectal NENs diagnosed between 2000 and 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER)-18 registries. Relative risk of SPCs was estimated as the standardized incidence ratio (SIR), which was calculated using SEER*Stat software.ResultsBetween 2000 and 2018, a total of 15836 patients diagnosed with rectal NENs, of whom 1436 (9.1%) received diagnosis of SPCs (SIR: 1.19, 95%CI: 1.13-1.26). The majority of patients were aged 50-69 and had their first cancer diagnosed at the localized stage. Male survivors had a higher propensity for developing SPCs overall, while female survivors exhibited higher risks of specific SPCs. Age at diagnosis of rectal NENs influenced the risk of SPCs, with younger patients having greater risks. A statistically significant increase in the incidence of SPCs was observed among patients aged 30-64 years. Black patients had higher relative risks of certain SPCs, while White patients had a lower risk of subsequent melanoma. Trend analysis revealed that the highest excess burden of SPCs was observed in the years 2000 to 2002. Risk of SPCs remained elevated within the first four years post-diagnosis for survivors of rectal NENs, but diminished thereafter.ConclusionThe study revealed that individuals who survived rectal NENs were at an elevated risk of developing SPCs compared to the general population. Our results hold important implications for the formulation of lifelong surveillance recommendations for cancer survivors.

学科与关键词

关键词
rectal NENssecond primary cancerSirEarSEER
相关
加载中…
  • Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study
    Ding, X.; Yang, X.; Hao, Q.; Xu, F.; Yu, X.; Rao, L.; Yuan, C.*; Tian, S.*Journal of Endocrinological Investigation, 2023, 46(9): 1881-1889.被引 1
  • The risk of developing second primary malignancies among colorectal cancer patients
    Du, Songtao; Li, Yayun; Sun, Huiyan; Deng, Guangtong; Tang, Siyuan; Zeng, Furong*; Zhang, Bomiao*; Cui, Binbin*Aging-US, 2022, 14(16): 6756-6779.被引 1
  • The incidence of second primary cancer in male and female patients with initial colorectal cancer: a SEER population-based study
    Chen, Yanyan; Han, Chao; Huang, Yadi; Liu, Chao; Sheng, Siqi; Ji, Linlin; Zhu, Jialong; Fu, Gongbo; Mao, Xiaobei; Huang, Mengxi; Lei, Zengjie; Chu, Xiaoyuan*EUROPEAN JOURNAL OF CANCER PREVENTION, 2022, 31(5): 430-441.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-09-13
卷期
第 13 卷
页码
1248268
DOI
10.3389/fonc.2023.1248268
成果收录
SCIE

作者

  • W

    Wan, Ming (第一作者)

    2 · harbin med univ

  • W

    Wu, Jiaqi

    2 · harbin med univ

查看全部 5 位作者收起作者
  • J

    Jiang, Zhaopeng

    2 · harbin med univ

  • G

    Gong, Wushuang

    2 · harbin med univ

  • Z

    Zhou, Xianli (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417